Pillar Biosciences
Focus: Pillar Biosciences develops targeted next-generation sequencing (NGS)-based assays and software for precision diagnostics, with a current focus on ophthalmology applications. The company is positioned as a specialized biotech player leveraging molecular diagnostics and liquid biopsy technologies.
Profile data last refreshed 6h ago · AI intelligence enriched 3w ago
Open Jobs
1
Should You Work at Pillar Biosciences?
AI assessmentPillar Biosciences is an early-stage precision diagnostics company with strong visa-sponsorship track record, but minimal hiring activity and undisclosed financial position make it a speculative career move suitable only for founders-mentality or deep NGS/liquid-biopsy specialists.
Why Work Here
- Perfect 7-0 H1B approval rate in 2023 signals company is actively hiring specialized talent and willing to sponsor visas without friction
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Recent News · Pillar Biosciences(10)
Help build intelligence for Pillar Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.